KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Biocryst Pharmaceuticals (BCRX) Accumulated Depreciation & Amortization (2016 - 2025)

Biocryst Pharmaceuticals filings provide 16 years of Accumulated Depreciation & Amortization readings, the most recent being $1.4 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 11.48% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a 11.48% increase, with the full-year FY2025 number at $1.4 million, up 11.48% from a year prior.
  • Accumulated Depreciation & Amortization hit $1.4 million in Q4 2025 for Biocryst Pharmaceuticals, up from $1.2 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $1.7 million in Q4 2023 to a low of $777000.0 in Q4 2021.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $1.4 million (2025), compared with a mean of $1.3 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: skyrocketed 84.94% in 2022 and later fell 24.71% in 2024.
  • Biocryst Pharmaceuticals' Accumulated Depreciation & Amortization stood at $777000.0 in 2021, then surged by 84.94% to $1.4 million in 2022, then grew by 15.17% to $1.7 million in 2023, then decreased by 24.71% to $1.2 million in 2024, then grew by 11.48% to $1.4 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $1.4 million (Q4 2025), $1.2 million (Q4 2024), and $1.7 million (Q4 2023) per Business Quant data.